GILL SIMBA (President & CEO) sold 8.3% of their position (342.00 shares) of EVELO BIOSCIENCES, INC. on the open market
Open‑market sale worth $3.3K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/9/2023ACC: 0001694665-23-000135
DirectorOfficer· President & CEO
Since Jan 2019
-342.00
Net shares
Net seller
$3.3K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
1.17K acquired · 1.51K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+1.17K
Price / share
—
Trade value
—
% of position
40.0%
8/7/2023
2.92K→4.10K
Common Stock
Direct
Shares
−342.00
Price / share
$9.51
Trade value
$3.25K
% of position
8.3%
8/8/2023
4.10K→3.75K
Total
Net shares
+829.00
Net value
-$3.25K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/7/2023 | M · Option Exercise | +1.17K | — | — | 40.0% | 2.92K | 4.10K |
| Common Stock Direct | 8/8/2023 | S · Sale | −342.00 | $9.51 | $3.25K | 8.3% | 4.10K | 3.75K |
| Total | +829.00 | -$3.25K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
1.17K shares
Shares
−1.17K
Strike price
Held after
16.41K
Exercisable
—
8/7/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock1.17K shares | 8/7/2023 | M · Option Exercise | −1.17K | — | 16.41K |